Overview

Predictive Factors Study

Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This is a long term study to evaluate common therapeutic algorithms and possible predictive parameters for Somatuline Autogel treatment in patients with Acromegaly.
Details
Lead Sponsor:
Ipsen
Treatments:
Angiopeptin
Lanreotide
Somatostatin